This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Atropine Injection BP 0.4MG/ML (2015-11-19)

Starting date:
November 19, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55944

Affected Products

Atropine Injection BP 0.4MG/ML

Reason

One lot of Atropine Injection BP 0.4 mg/mL (DIN 02094681) (L) 50187 marketed and sold by Alveda Pharmaceuticals Inc. is being recalled, due to an incorrect barcode on the ampoule label. The barcode reads (01)00837641000591 which is that same barcode as on the ampoule label of Alveda Epinephrine Injection USP 1 mg/mL (DIN 02325225).

Depth of distribution

Wholesalers and sub-recall to physicians, hospitals and hospital Pharmacists in Alberta, British Columbia, Ontario, New Brunswick, Newfoundland, Nova Scotia, Manitoba, Quebec, and Saskatchewan.

Affected products

Atropine Injection BP 0.4MG/ML

DIN, NPN, DIN-HIM
DIN 02094681
Dosage form

Solution

Strength

Atropine sulfate 0.4 mg/mL

Lot or serial number

50187

Companies
Recalling Firm
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA
Marketing Authorization Holder
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA